Psychometric Properties of the Chinese Version of Penn State [Electronic] Cigarette Dependence Index

September 5, 2023 updated by: Wei XIA, PhD, Sun Yat-sen University
The purpose of this study is to realize the first evaluation of the psychometric characteristics of the Chinese version of the the Penn State University Electronic Cigarette Dependence Index Scale.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study will use forward translation, reverse translation, and comprehensive methods to Chinese-translate the Penn State University Electronic Cigarette Dependence Index Scale to form a Chinese version of the Penn State University Electronic Cigarette Dependence Index Scale that is more in line with the Chinese language and cultural environment. This study will also verify its reliability and validity in a large sample population to form a formal version of the scale. The scale will provide an effective tool for evaluating the degree of e-cigarette dependence among young people and adolescents in my country.

Study Type

Observational

Enrollment (Actual)

320

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510080
        • XIAW

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

A total number of 275 adults who used nicotine-containing e-cigarettes at least once a week for the past month and have smoked daily for the last 3 months

Description

Inclusion Criteria:

  • (1)≥18 years old;
  • (2)Those who used e-cigarettes at least once a week for the past month;
  • (3)Be able to read and communicate in Chinese.

Exclusion Criteria:

  • Those who are unable to communicate due to serious mental or physical illnesses such as deafness, confusion caused by mental illness, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Questionnaires assessed e-cigarette users
  1. ≥18 years old;
  2. Those who used e-cigarettes at least once a week for the past month;
  3. Be able to read and communicate in Chinese.
Participants will be asked to respond to the demographic information sheet,e-cigarette using characteristics sheet,the Penn State Electronic Cigarette Dependence Index (PS-ECDI ).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
E-cigarette dependence
Time Frame: Baseline
The Penn State Electronic Cigarette Dependence Index is a validated self-reported instrument assessing e-cigarette dependence.Possible scales range from 0(no dependence) to 20(high dependency).
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported addiction
Time Frame: Baseline
Measured by a 0-100 point scale:the higher the score of the participant, the more severe the dependence on e-cigarettes.
Baseline
Time to first vape
Time Frame: Baseline
Corroborative evidence for e-cigarette dependence:the shorter the time interval, the greater the dependence on e-cigarettes.
Baseline
Vapes/day and vaping days/week
Time Frame: Baseline
Corroborative evidence for e-cigarette dependence:the higher the frequency, the more severe the dependence on e-cigarettes.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wei Xia, PhD, Sun Yat-sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 27, 2022

Primary Completion (Actual)

March 27, 2023

Study Completion (Actual)

May 30, 2023

Study Registration Dates

First Submitted

July 24, 2022

First Submitted That Met QC Criteria

July 27, 2022

First Posted (Actual)

July 28, 2022

Study Record Updates

Last Update Posted (Actual)

September 6, 2023

Last Update Submitted That Met QC Criteria

September 5, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • wjn-ChiCTR2200060896

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The non-identified individual participant data will be shared after the outcomes have been published.

IPD Sharing Time Frame

After the publication of the study.

IPD Sharing Access Criteria

Researchers should contact the PI for approval of the study protocol.

IPD Sharing Supporting Information Type

  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on E-Cig Use

Clinical Trials on Questionnaires set

3
Subscribe